The blood clots that led to the Johnson & Johnson suspensions had been all reported in the US. In South Africa, officers confirmed Thursday that no instances of clots have been reported among the many roughly 290,000 well being care employees who’ve obtained the vaccine to date.
“The short-term suspension in South Africa was according to authorities’s dedication to make sure complete measures are undertaken relating to vaccine rollout,” Khumbudzo Ntshavheni, a cupboard minister, informed reporters on Thursday.
Well being consultants welcomed the resumption of the vaccine marketing campaign in South Africa, which has recorded extra coronavirus instances than some other nation on the continent and has suffered severe setbacks in its try to fight the virus in latest months.
In February, well being officers scrapped plans to make use of the AstraZeneca vaccine after it proved ineffective in opposition to a variant of the virus now dominant in South Africa. The choice got here every week after a million doses of the vaccine arrived within the nation and amid a devastating second wave of virus instances.
Although the Johnson & Johnson vaccine has not but been accepted for basic use in South Africa, it has been used as a part of a analysis examine providing early entry to the vaccine to the nation’s 1.2 million well being care employees.